Original Article

You have full text access to this OnlineOpen article

Osteosarcoma of the jaw/craniofacial region

Outcomes after multimodality treatment

  1. B. Ashleigh Guadagnolo MD, MPH1,†,*,
  2. Gunar K. Zagars MD1,
  3. A. Kevin Raymond MD2,
  4. Robert S. Benjamin MD3,
  5. Erich M. Sturgis MD, MPH4,5

Article first published online: 20 APR 2009

DOI: 10.1002/cncr.24297

Issue

Cancer

Cancer

Volume 115, Issue 14, pages 3262–3270, 15 July 2009

Additional Information

How to Cite

Guadagnolo, B. A., Zagars, G. K., Raymond, A. K., Benjamin, R. S. and Sturgis, E. M. (2009), Osteosarcoma of the jaw/craniofacial region. Cancer, 115: 3262–3270. doi: 10.1002/cncr.24297

Author Information

  1. 1

    Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  3. 3

    Department of Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  4. 4

    Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  5. 5

    Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. †

    Fax: (713) 563-2331

*Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX 77030

Publication History

  1. Issue published online: 15 JUL 2009
  2. Article first published online: 20 APR 2009
  3. Manuscript Accepted: 9 FEB 2009
  4. Manuscript Received: 29 JAN 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (172K)

References

  • 1
    Dahlin DC,Unni KK. Osteosarcoma Bone Tumors. Springfield, Ill: Charles C. Thomas Publisher; 1986: 269-307.
  • 2
    Sturgis EM,Potter BO. Sarcomas of the head and neck region. Curr Opin Oncol. 2003; 15: 239-252.
  • 3
    Garrington GE,Scofield HH,Cornyn J,Hooker SP. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer. 1967; 20: 377-391.
    Direct Link:
  • 4
    Clark JL,Unni KK,Dahlin DC,Devine KD. Osteosarcoma of the jaw. Cancer. 1983; 51: 2311-2316.
    Direct Link:
  • 5
    Laskar S,Basu A,Muckaden MA, et al. Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients. Head Neck. 2008; 30: 1020-1026.
    Direct Link:
  • 6
    Jasnau S,Meyer U,Potratz J, et al. Craniofacial osteosarcoma. Experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol. 2008; 44: 286-294.
  • 7
    van Es RJ,Keus RB,van der Waal I,Koole R,Vermey A. Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg. 1997; 26: 191-197.
  • 8
    Patel SG,Meyers P,Huvos AG, et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer. 2002; 95: 1495-1503.
    Direct Link:
  • 9
    Canadian Society of Otolaryngology-Head and Neck Surgery Oncology Study Group. Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol. 2004; 33: 139-144.
  • 10
    August M,Magennis P,Dewitt D. Osteogenic sarcoma of the jaws: factors influencing prognosis. Int J Oral Maxillofac Surg. 1997; 26: 198-204.
  • 11
    Bertoni F,Dallera P,Bacchini P,Marchetti C,Campobassi A. The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer. 1991; 68: 1555-1563.
    Direct Link:
  • 12
    Ha PK,Eisele DW,Frassica FJ,Zahurak ML,McCarthy EF. Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope. 1999; 109: 964-969.
    Direct Link:
  • 13
    Fernandes R,Nikitakis NG,Pazoki A,Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg. 2007; 65: 1286-1291.
  • 14
    Oda D,Bavisotto LM,Schmidt RA, et al. Head and neck osteosarcoma at the University of Washington. Head Neck. 1997; 19: 513-523.
    Direct Link:
  • 15
    Thiele OC,Freier K,Bacon C,Egerer G,Hofele CM. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study. Br J Oral Maxillofac Surg. 2008; 46: 533-536.
  • 16
    Kaplan E,Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
  • 17
    Cox D. Regression models and life tables. J R Stat Soc B. 1972; 34: 187-220.
  • 18
    Smeele LE,Kostense PJ,van der Waal I,Snow GB. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol. 1997; 15: 363-367.
  • 19
    Bruland OS,Hoifodt H,Saeter G,Smeland S,Fodstad O. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res. 2005; 11: 4666-4673.
  • 20
    Eilber F,Giuliano A,Eckardt J,Patterson K,Moseley S,Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol. 1987; 5: 21-26.
  • 21
    Link MP,Goorin AM,Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986; 314: 1600-1606.
  • 22
    Link MP,Goorin AM,Horowitz M, et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res. 1991;(270): 8-14.
  • 23
    Goorin AM,Schwartzentruber DJ,Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003; 21: 1574-1580.
View Full Article (HTML) Get PDF (172K)